The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Crowley Richard since year 2005.
The trader's CIK number is 1352961.
At the time of this reporting, Crowley Richard is the SVP, Biopharmaceutical Ops of Imclone Systems Inc/de .
(stock ticker symbol IMCL).
See this page for all insider trading activities at Imclone Systems Inc/de .
Stock purchases, sales, and option exercises reported by insider Crowley Richard since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-11-03
IMCL
Imclone Systems Inc/de
Option Exercise
11,957
27.94
334,048
2008-11-03
IMCL
Imclone Systems Inc/de
Sale
11,957
68.72
821,685
2008-09-02
IMCL
Imclone Systems Inc/de
Sale
11,957
64.40
770,030
2008-09-02
IMCL
Imclone Systems Inc/de
Option Exercise
11,957
27.94
334,048
2007-11-19
IMCL
Imclone Systems Inc/de
Sale
11,957
64.16
767,161
2008-07-31
IMCL
Imclone Systems Inc/de
Option Exercise
26,957
29.88
805,340
2008-07-31
IMCL
Imclone Systems Inc/de
Sale
15,000
64.16
962,400
2008-02-15
IMCL
Imclone Systems Inc/de
Option Exercise
2,667
.00
0
2007-11-19
IMCL
Imclone Systems Inc/de
Sale
9,150
42.65
390,247
2007-11-19
IMCL
Imclone Systems Inc/de
Option Exercise
9,150
9.42
86,238
2006-07-03
IMCL
Imclone Systems Inc/de
Sale
1,000
38.68
38,675
2006-07-03
IMCL
Imclone Systems Inc/de
Option Exercise
1,000
6.94
6,940
2006-06-01
IMCL
Imclone Systems Inc/de
Option Exercise
1,000
6.94
6,940
2006-06-01
IMCL
Imclone Systems Inc/de
Sale
1,000
39.84
39,840
2006-05-01
IMCL
Imclone Systems Inc/de
Option Exercise
1,000
6.94
6,940
2006-05-01
IMCL
Imclone Systems Inc/de
Sale
1,000
35.96
35,960
2006-04-21
IMCL
Imclone Systems Inc/de
Option Exercise
1,000
6.94
6,940
2006-04-21
IMCL
Imclone Systems Inc/de
Sale
1,000
35.00
35,000
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Crowley Richard
(SVP, Biopharmaceutical Ops of Imclone Systems Inc/de at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
